To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene PGPandC16orf79TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
268 supporting clones for gene PGPandC16orf79 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BF967085 brain, hypothalamus .a 1 to 458 1 to 446   tiling clone, fully sequenced,   446/446
(100 %)
8 diff
(98.3 %id)
CR977710 T-Lymphocytes .a 18 to 325 1 to 309       309/309
(100 %)
2 diff
(99.4 %id)
CR988953 T-Lymphocytes .a 22 to 676 1 to 657       657/657
(100 %)
4 diff
(99.4 %id)
AW161386 brain, frontal lobe .a 25 to 509 1 to 485       485/485
(100 %)
1 diff
(99.8 %id)
NM_001042371.2   .a 25 to 3160 1 to 3136   RefSeq,   3136/3136
(100 %)
0 diff
(100 %id)
BG925852 cartilage .a 28 to 382 86 to 440       355/372
(95 %)
6 diff
(98.4 %id)
BI462462 testis .a 28 to 707 1 to 675       675/675
(100 %)
13 diff
(98.1 %id)
TI_44166424   .a 29 to 710 82 to 764       683/768
(88 %)
9 diff
(98.9 %id)
BI546421 brain, hippocampus .a 32 to 710 1 to 679       679/683
(99 %)
7 diff
(99.0 %id)
DN993166 brain, whole brain .a 32 to 549 1 to 518       518/518
(100 %)
4 diff
(99.3 %id)
BQ049731 lymph, lymphoma, cell line .a 37 to 709 1 to 675       675/1154
(58 %)
4 diff
(99.7 %id)
BG702240 brain, hippocampus .a 38 to 707 1 to 674       674/674
(100 %)
10 diff
(98.6 %id)
BX331494 Neuroblastoma Cot 10-normalized .a 39 to 896 1 to 855       855/855
(100 %)
29 diff
(96.7 %id)
BI196522 brain, neuroblastoma .a 42 to 863 1 to 830       830/831
(99 %)
17 diff
(98.0 %id)
BI199234 brain, neuroblastoma .a 42 to 834 1 to 823       823/947
(86 %)
48 diff
(95.0 %id)
BX325412   .a 43 to 967 1 to 922       922/925
(99 %)
9 diff
(99.1 %id)
DB636477 hippocampus .a 44 to 529 1 to 482       482/696
(69 %)
35 diff
(95.0 %id)
BI545747 brain, hippocampus .a 45 to 806 1 to 759       759/759
(100 %)
9 diff
(98.9 %id)
BU568241 testis .a 45 to 559 1 to 520       520/892
(58 %)
18 diff
(98.0 %id)
BI459524 testis .a 46 to 805 1 to 763       763/763
(100 %)
18 diff
(97.7 %id)
TI_44166208   .a 46 to 806 119 to 876       758/876
(86 %)
10 diff
(98.9 %id)
AW732531 Kidney, renal cell adenocarcinoma .a 52 to 520 1 to 470       470/470
(100 %)
2 diff
(99.6 %id)
BX384310   .a 60 to 1059 1 to 992   AAA   992/992
(100 %)
19 diff
(98.1 %id)
BQ428049 leiomyosarcoma, uterus .a 60 to 429 1 to 374       374/994
(37 %)
7 diff
(99.3 %id)
CN371370 embryonic stem cells, cell lines H1, H7, andH9 .a 61 to 606 1 to 546       546/546
(100 %)
0 diff
(100 %id)
DB461931 testis .a 61 to 540 1 to 480       480/481
(99 %)
4 diff
(99.2 %id)
BC035985 Brain, glioblastoma .a 61 to 1077 1 to 1017   tiling clone, available from MGC, AAA   1017/1017
(100 %)
0 diff
(100 %id)
BG753036 eye, normal pigmented retinal epithelium .a 62 to 899 1 to 854       854/857
(99 %)
16 diff
(98.2 %id)
BM561230 amelanotic melanoma, cell line, skin .a 63 to 709 1 to 650       650/1172
(55 %)
11 diff
(99.1 %id)
BM559661 amelanotic melanoma, cell line, skin .a 63 to 432 1 to 370       370/1430
(25 %)
8 diff
(99.5 %id)
CN371369 embryonic stem cells, DMSO-treated H9 cellline .a 69 to 726 1 to 662       662/662
(100 %)
3 diff
(99.6 %id)
CR606733 thymus .a 71 to 1034 1 to 964       964/964
(100 %)
0 diff
(100 %id)
BX457324 thymus .a 71 to 961 1 to 889       889/889
(100 %)
6 diff
(99.4 %id)
CN484794 eye .a 71 to 270 1 to 200       200/200
(100 %)
2 diff
(99.0 %id)
BM547562 brain, hippocampus .a 74 to 596 20 to 542       523/1360
(38 %)
16 diff
(98.9 %id)
BQ269504 Pancreas, Purified pancreatic islet .a 80 to 698 1 to 619       619/619
(100 %)
3 diff
(99.6 %id)
BE885085 leiomyosarcoma, uterus .a 93 to 816 1 to 721       721/798
(90 %)
18 diff
(97.8 %id)
BI488636 brain .a 106 to 970 1 to 866       866/866
(100 %)
42 diff
(95.2 %id)
TI_45379252   .a 107 to 970 68 to 932       865/932
(92 %)
35 diff
(96.3 %id)
AW328558 cervix .a 113 to 672 8 to 568   fully sequenced,   561/568
(98 %)
6 diff
(99.0 %id)
BE907224 epithelioid carcinoma, Pancreas .a 130 to 803 1 to 673       673/673
(100 %)
2 diff
(99.8 %id)
CK825763 Pancreas, Purified pancreatic islet .a 131 to 687 1 to 557     Submitted on the opposite strand 557/557
(100 %)
0 diff
(100 %id)
AA449572   .a 140 to 221 1 to 82       82/82
(100 %)
0 diff
(100 %id)
BM562881 astrocytoma grade IV, cell line, brain .a 153 to 951 1 to 811       811/1072
(75 %)
27 diff
(97.5 %id)
DB499966 hypothalamus .a 204 to 699 1 to 496       496/496
(100 %)
1 diff
(99.8 %id)
TI_57163022   .a 228 to 928 25 to 724       700/728
(96 %)
7 diff
(99.1 %id)
BI838383 pooled pancreas and spleen .a 235 to 928 1 to 694       694/698
(99 %)
1 diff
(99.9 %id)
BU172377 melanotic melanoma, cell line, skin .a 272 to 1061 855 to 61   AAA Submitted on the opposite strand 795/917
(86 %)
31 diff
(96.7 %id)
BF316045 brain, neuroblastoma .a 285 to 746 260 to 731       696/731
(95 %)
45 diff
(93.9 %id)
BG284709 adenocarcinoma, cell line, Prostate .a 403 to 1070 1 to 666       666/668
(99 %)
8 diff
(98.9 %id)
BU538281 adenocarcinoma, cell line, breast .a 407 to 1077 41 to 711   AAA   671/711
(94 %)
8 diff
(98.9 %id)
DB527351 testis .a 424 to 1077 1 to 650     Submitted on the opposite strand 650/650
(100 %)
12 diff
(98.2 %id)
BF967720 brain, hypothalamus .a 428 to 1015 606 to 16   fully sequenced,   591/606
(97 %)
6 diff
(99.1 %id)
BU160798 melanotic melanoma, cell line, skin .a 439 to 1061 654 to 26   AAA Submitted on the opposite strand 629/903
(69 %)
16 diff
(98.3 %id)
BQ286142 Pancreas, Purified pancreatic islet .a 441 to 1060 620 to 1       620/620
(100 %)
0 diff
(100 %id)
BU185832 melanotic melanoma, cell line, skin .a 441 to 1069 646 to 18   AAA Submitted on the opposite strand 629/933
(67 %)
9 diff
(99.1 %id)
BQ892649 melanotic melanoma, cell line, skin .a 476 to 1061 616 to 26   AAA Submitted on the opposite strand 591/1014
(58 %)
13 diff
(98.8 %id)
AA393657   .a 477 to 877 1 to 419       425/419
(101 %)
19 diff
(95.5 %id)
BU174676 ductal carcinoma, cell line, Pancreas .a 501 to 1083 1 to 583   AAA   583/583
(100 %)
1 diff
(99.9 %id)
BU146424 ductal carcinoma, cell line, Pancreas .a 501 to 1083 1 to 583   AAA   583/583
(100 %)
0 diff
(100 %id)
BQ888679 ductal carcinoma, cell line, Pancreas .a 501 to 1053 1 to 559       559/1143
(48 %)
14 diff
(98.8 %id)
BQ686040 ductal carcinoma, cell line, Pancreas .a 501 to 1083 1 to 583   AAA   583/583
(100 %)
0 diff
(100 %id)
CA308791 Alveolar Macrophage, lung .a 502 to 1077 592 to 17   AAA   576/585
(98 %)
0 diff
(100 %id)
CA308803 Alveolar Macrophage, lung .a 502 to 1077 592 to 17   AAA   576/585
(98 %)
13 diff
(97.8 %id)
BQ683658 melanotic melanoma, cell line, skin .a 512 to 1061 579 to 26   AAA Submitted on the opposite strand 554/993
(55 %)
18 diff
(98.2 %id)
AW439523 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 513 to 1080 568 to 1       568/568
(100 %)
1 diff
(99.9 %id)
BU190809 melanotic melanoma, cell line, skin .a 516 to 1061 571 to 26   AAA Submitted on the opposite strand 546/923
(59 %)
5 diff
(99.5 %id)
AA563976 colon, tumor .a 549 to 1051 504 to 1       504/504
(100 %)
14 diff
(97.3 %id)
AI819340 pooled .a 549 to 1081 536 to 3       534/539
(99 %)
0 diff
(100 %id)
BE855892 brain, glioblastoma (pooled) .a 555 to 1077 523 to 1       523/523
(100 %)
0 diff
(100 %id)
BE855786 brain, glioblastoma (pooled) .a 555 to 1077 523 to 1       523/523
(100 %)
1 diff
(99.9 %id)
AI367310 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 558 to 1077 520 to 1       520/520
(100 %)
0 diff
(100 %id)
AI291018 carcinoid, lung .a 573 to 1061 489 to 1       489/489
(100 %)
0 diff
(100 %id)
DW412988 Liver .a 589 to 893 17 to 322       306/322
(95 %)
8 diff
(97.6 %id)
AI421797 brain, glioblastoma (pooled) .a 591 to 1077 487 to 1       487/487
(100 %)
7 diff
(98.6 %id)
AW157839 brain, frontal lobe .a 591 to 1068 478 to 1       478/478
(100 %)
3 diff
(99.4 %id)
AA285266   .a 598 to 912 1 to 315       315/318
(99 %)
8 diff
(97.5 %id)
AA861557   .a 600 to 1077 491 to 15   AAA   477/477
(100 %)
6 diff
(98.8 %id)
CB148211 brain .a 606 to 1069 1 to 464       464/464
(100 %)
2 diff
(99.6 %id)
BM792601 Ascites, stomach .a 607 to 1083 1 to 477   AAA   477/477
(100 %)
3 diff
(99.4 %id)
W86181 liver and spleen .a 622 to 1063 449 to 1       449/451
(99 %)
13 diff
(97.2 %id)
AA393284   .a 629 to 872 1 to 242   fully sequenced,   242/242
(100 %)
4 diff
(98.4 %id)
AI279568 carcinoid, lung .a 630 to 1061 443 to 12   AAA   432/432
(100 %)
0 diff
(100 %id)
BF792102 adrenal cortex carcinoma, cell line, adrenal gland .a 632 to 1061 1 to 430   AAA   430/430
(100 %)
0 diff
(100 %id)
AI817949 anaplastic oligodendroglioma, brain .a 636 to 1081 477 to 6       433/477
(90 %)
7 diff
(98.6 %id)
AW086007 esophagus, squamous cell carcinoma .a 647 to 1062 418 to 1       418/418
(100 %)
11 diff
(97.4 %id)
AI952581 normal epithelium, ovary .a 648 to 1077 440 to 11   AAA   430/430
(100 %)
1 diff
(99.8 %id)
AA455039 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 656 to 1061 425 to 20   AAA   406/406
(100 %)
4 diff
(99.1 %id)
BX109989 liver and spleen .a 661 to 1077 7 to 424   AAA   418/424
(98 %)
6 diff
(98.6 %id)
CN276794 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 664 to 1068 1 to 405       405/405
(100 %)
0 diff
(100 %id)
AW328559 cervix .a 665 to 1077 438 to 26   fully sequenced, AAA   413/413
(100 %)
1 diff
(99.8 %id)
EC441982 Prostate .a 682 to 785 1 to 104       104/104
(100 %)
0 diff
(100 %id)
BE673215 Prostate .a 687 to 1078 392 to 1       392/504
(77 %)
2 diff
(99.7 %id)
AI475459 colon, moderately-differentiated adenocarcinoma .a 695 to 1061 366 to 1       366/366
(100 %)
1 diff
(99.8 %id)
AI016119   .a 697 to 1081 389 to 4       386/389
(99 %)
0 diff
(100 %id)
BM692097 eye, human retina .a 698 to 1077 1 to 380   fully sequenced, AAA   380/380
(100 %)
0 diff
(100 %id)
F26970 pectoral muscle (after mastectomy) .a 702 to 814 1 to 113       113/113
(100 %)
6 diff
(94.7 %id)
R08892 liver and spleen .a 704 to 1069 370 to 1       370/382
(96 %)
6 diff
(98.5 %id)
BQ219475 epithelioid carcinoma, Pancreas .a 704 to 1535 12 to 853       842/878
(95 %)
24 diff
(97.3 %id)
BM829682 stomach .a 704 to 1028 31 to 355       325/355
(91 %)
6 diff
(98.4 %id)
AA903454 leiomyosarcoma, soft tissue .a 705 to 993 289 to 1       289/289
(100 %)
0 diff
(100 %id)
AI885838 anaplastic oligodendroglioma, brain .a 707 to 1062 356 to 1       356/356
(100 %)
0 diff
(100 %id)
AI857317 anaplastic oligodendroglioma, brain .a 708 to 1062 356 to 2       355/357
(99 %)
0 diff
(100 %id)
F37044 pectoral muscle (after mastectomy) .a 719 to 1081 1 to 363       363/365
(99 %)
3 diff
(99.2 %id)
BF435189 pooled .a 721 to 1081 362 to 2       361/363
(99 %)
0 diff
(100 %id)
DW455962 Liver .a 732 to 885 17 to 171       155/171
(90 %)
6 diff
(96.5 %id)
BF221978 Prostate .a 738 to 1077 340 to 1       340/340
(100 %)
1 diff
(99.8 %id)
BU933259 mixed (pool of 40 RNAs) .a 741 to 1089 1 to 348       348/371
(93 %)
7 diff
(98.2 %id)
F26974 pectoral muscle (after mastectomy) .a 743 to 903 1 to 161       161/161
(100 %)
1 diff
(99.4 %id)
AA641660 invasive tumor (cell line), Prostate .a 744 to 1077 350 to 18   AAA   333/342
(97 %)
0 diff
(100 %id)
AA449316   .a 745 to 1084 345 to 6       340/345
(98 %)
0 diff
(100 %id)
AA745939 Kidney .a 745 to 1077 345 to 13   AAA   333/333
(100 %)
0 diff
(100 %id)
AW516470 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 765 to 1061 301 to 1       301/327
(92 %)
10 diff
(97.0 %id)
BF432715 carcinoid, lung .a 768 to 1044 1 to 277     Submitted on the opposite strand 277/277
(100 %)
0 diff
(100 %id)
BM700293 eye, lens .a 777 to 1079 1 to 304   AAA   304/304
(100 %)
2 diff
(99.4 %id)
DA519395 brain .a 783 to 1327 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
EC466333 Prostate .a 784 to 852 18 to 86       69/86
(80 %)
8 diff
(90.7 %id)
AA299937 uterus .a 797 to 1077 1 to 281       281/281
(100 %)
0 diff
(100 %id)
BQ678957 melanotic melanoma, cell line, skin .a 801 to 1061 286 to 26   AAA Submitted on the opposite strand 261/262
(99 %)
0 diff
(100 %id)
AA483810 colon .a 819 to 1058 240 to 1       240/240
(100 %)
1 diff
(99.6 %id)
AI910965 pooled .a 824 to 1081 259 to 2       258/259
(99 %)
0 diff
(100 %id)
T82295   .a 832 to 1061 241 to 13   AAA   229/229
(100 %)
1 diff
(99.6 %id)
AA398629   .a 842 to 1064 222 to 1   fully sequenced,   222/222
(100 %)
0 diff
(100 %id)
AA535753 invasive prostate tumor, Prostate .a 857 to 1061 226 to 22   AAA   205/213
(96 %)
0 diff
(100 %id)
AI581592 colon .a 868 to 1056 191 to 3       189/191
(98 %)
0 diff
(100 %id)
BU728844 eye, human retina .a 878 to 1077 218 to 19   fully sequenced, AAA   200/200
(100 %)
0 diff
(100 %id)
AA400837   .a 879 to 1077 199 to 1       199/199
(100 %)
0 diff
(100 %id)
AW151447 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 885 to 1077 193 to 1       193/193
(100 %)
0 diff
(100 %id)
F10715 brain, total brain .a 888 to 1077 190 to 1       190/190
(100 %)
0 diff
(100 %id)
AA894370 Kidney .a 891 to 1077 188 to 1       188/188
(100 %)
1 diff
(99.5 %id)
DA322404 hippocampus .a 920 to 1483 2 to 567   capped   566/566
(100 %)
3 diff
(99.5 %id)
BF810689 colon_ins .a 927 to 1198 279 to 11     Submitted on the opposite strand 269/296
(90 %)
0 diff
(100 %id)
BQ325873 colon_ins .a 927 to 1154 227 to 1       227/228
(99 %)
13 diff
(94.3 %id)
DA336356 hippocampus .a 930 to 1499 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
CA336719 posterior rhombomeres 5-8 (4 pooled) .a 930 to 1077 1 to 148   AAA   148/148
(100 %)
0 diff
(100 %id)
BM802919 duodenal adenocarcinoma, cell line, small intestine .a 960 to 1535 1 to 578       578/1172
(49 %)
10 diff
(99.2 %id)
CA312048 Human Lung Epithelial cells, lung .a 971 to 1061 106 to 16   AAA   91/100
(91 %)
0 diff
(100 %id)
CD677837 eye, Trabecular meshwork .a 981 to 1077 1 to 97   AAA   97/97
(100 %)
1 diff
(99.0 %id)
GD158690   .a 1017 to 1068 1 to 52       52/52
(100 %)
2 diff
(96.2 %id)
BG287508 bladder, transitional cell papilloma, cell line .a 1036 to 1707 1 to 667   AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 667/670
(99 %)
10 diff
(98.6 %id)
DA093755 cerebellum .a 1060 to 1467 2 to 409   capped   408/408
(100 %)
1 diff
(99.8 %id)
DA104784 cerebellum .a 1061 to 1613 2 to 556   capped   555/555
(100 %)
3 diff
(99.5 %id)
DA099067 cerebellum .a 1070 to 1622 2 to 554   tiling clone, capped   553/553
(100 %)
1 diff
(99.9 %id)
DA121974 cerebellum .a 1072 to 1541 2 to 471   capped   470/470
(100 %)
2 diff
(99.6 %id)
DA068054 cerebellum .a 1086 to 1659 2 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
DB290899 uterus .a 1087 to 1593 2 to 508   capped   507/507
(100 %)
2 diff
(99.7 %id)
DA110310 cerebellum .a 1121 to 1678 2 to 560   capped   559/559
(100 %)
3 diff
(99.5 %id)
BC002330 Lung, small cell carcinoma .a 1129 to 2764 1 to 1635   tiling clone, available from MGC, AAA   1635/1635
(100 %)
1 diff
(100.0 %id)
DA628631 Kidney .a 1145 to 1666 2 to 523   capped   522/522
(100 %)
2 diff
(99.7 %id)
CN255345 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1151 to 1674 1 to 524       524/524
(100 %)
3 diff
(99.5 %id)
DA109196 cerebellum .a 1153 to 1723 2 to 572   capped   571/571
(100 %)
2 diff
(99.7 %id)
BE267466 lung, small cell carcinoma .a 1179 to 1916 66 to 803   available from MGC,   738/870
(84 %)
22 diff
(97.5 %id)
AK026146   .a 1210 to 2764 1 to 1559   available from FLJ, AAA   1559/1559
(100 %)
6 diff
(99.7 %id)
DB062697 testis .a 1210 to 1744 2 to 536   capped   535/535
(100 %)
2 diff
(99.7 %id)
DA238182 brain .a 1223 to 1796 2 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
CB154941 brain .a 1228 to 1544 1 to 317       317/317
(100 %)
2 diff
(99.4 %id)
DA170227 amygdala .a 1241 to 1759 2 to 520   capped   519/519
(100 %)
3 diff
(99.5 %id)
BI003343 head_normal .a 1280 to 1741 461 to 1       461/461
(100 %)
7 diff
(98.5 %id)
CN255343 embryonic stem cells, cell lines H1, H7, andH9 .a 1280 to 1896 1 to 620       620/620
(100 %)
4 diff
(99.4 %id)
BQ425695 melanotic melanoma, skin .a 1293 to 2051 1 to 775   AAA   775/922
(84 %)
38 diff
(95.9 %id)
DA091354 cerebellum .a 1317 to 1796 2 to 481   capped   480/480
(100 %)
2 diff
(99.6 %id)
CN255342 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1333 to 1862 1 to 534       534/534
(100 %)
3 diff
(99.5 %id)
F05833 brain, total brain .a 1340 to 1549 1 to 210       210/210
(100 %)
1 diff
(99.6 %id)
Z42571 brain, total brain .a 1340 to 1598 1 to 259       259/259
(100 %)
0 diff
(100 %id)
BG257561 embryonal carcinoma, cell line, testis .a 1345 to 2153 1 to 805       805/807
(99 %)
23 diff
(97.2 %id)
DA214575 brain .a 1381 to 1826 2 to 447   capped   446/446
(100 %)
0 diff
(100 %id)
BG390784 embryonal carcinoma, cell line, testis .a 1407 to 1963 1 to 564       564/713
(79 %)
12 diff
(98.4 %id)
CN255344 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1411 to 1967 1 to 558       558/560
(99 %)
5 diff
(99.2 %id)
BM450360 eye, retinoblastoma .a 1423 to 2328 13 to 929       917/1086
(84 %)
35 diff
(96.8 %id)
BP431248   .a 1443 to 1805 1 to 364       364/364
(100 %)
6 diff
(98.4 %id)
DA125211 cerebellum .a 1445 to 1911 2 to 473   capped   472/472
(100 %)
5 diff
(99.0 %id)
DT216926 brain .a 1491 to 2151 1 to 665       665/665
(100 %)
3 diff
(99.6 %id)
BX488435   .a 1528 to 1956 1 to 429       429/429
(100 %)
1 diff
(99.8 %id)
CX754894 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 1538 to 2265 1 to 732     Submitted on the opposite strand 732/732
(100 %)
6 diff
(99.2 %id)
F00417 leg muscle, skeletal muscle .a 1639 to 1827 10 to 198       189/198
(95 %)
0 diff
(100 %id)
BM709268 eye, optic nerve .a 1688 to 2139 1 to 456       456/456
(100 %)
2 diff
(99.6 %id)
DA843386 placenta .a 1726 to 2292 2 to 572   capped   571/571
(100 %)
2 diff
(99.7 %id)
DR761497 embryonic stem .a 1734 to 2509 1 to 776       776/776
(100 %)
0 diff
(100 %id)
BM691846 eye, human retina .a 1741 to 2204 1 to 464       464/464
(100 %)
5 diff
(99.0 %id)
BG289134 bladder, transitional cell papilloma, cell line .a 1743 to 2509 1 to 773       773/1125
(68 %)
15 diff
(98.7 %id)
BX325411   .a 1754 to 2731 981 to 1       981/983
(99 %)
15 diff
(98.5 %id)
CN277638 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1815 to 2177 1 to 368       368/368
(100 %)
6 diff
(98.4 %id)
BX331493 Neuroblastoma Cot 10-normalized .a 1839 to 2733 901 to 8       894/906
(98 %)
0 diff
(100 %id)
AA227627 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1844 to 1957 1 to 113       113/113
(100 %)
1 diff
(99.2 %id)
DA239094 brain .a 1850 to 2410 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
H48875 liver and spleen .a 1854 to 2266 1 to 419       419/421
(99 %)
13 diff
(97.0 %id)
AA193644 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1875 to 2143 1 to 271       271/271
(100 %)
8 diff
(97.1 %id)
T97099 liver and spleen .a 1917 to 2284 1 to 375       375/375
(100 %)
12 diff
(96.8 %id)
DA111401 cerebellum .a 1975 to 2528 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DB536512 hippocampus .a 2033 to 2764 1 to 730     Submitted on the opposite strand 730/730
(100 %)
9 diff
(98.8 %id)
BU609215 Human Lung Epithelial cells, lung .a 2051 to 2764 728 to 19   AAA   710/710
(100 %)
6 diff
(99.2 %id)
R99677 liver and spleen .a 2086 to 2319 1 to 233   fully sequenced,   233/233
(100 %)
4 diff
(98.3 %id)
DA299407 hippocampus .a 2087 to 2642 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
BG675172 skin .a 2105 to 2764 1 to 661   AAA   661/661
(100 %)
3 diff
(99.6 %id)
CD369116 Alveolar Macrophage, lung .a 2152 to 2764 631 to 19   AAA   613/613
(100 %)
0 diff
(100 %id)
BU728702 eye, human retina .a 2265 to 2764 518 to 19   AAA   500/500
(100 %)
1 diff
(99.8 %id)
DB571112 hypothalamus .a 2291 to 2764 1 to 474     Submitted on the opposite strand 474/474
(100 %)
2 diff
(99.6 %id)
R99571 liver and spleen .a 2291 to 2770 479 to 3   fully sequenced,   477/479
(99 %)
0 diff
(100 %id)
AA227915 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2302 to 2765 468 to 6       463/469
(98 %)
0 diff
(100 %id)
BU732416 eye, optic nerve .a 2309 to 2764 474 to 19   AAA   456/456
(100 %)
2 diff
(99.6 %id)
BI040599 nervous_tumor .a 2315 to 2509 195 to 1       195/195
(100 %)
1 diff
(99.5 %id)
R88802 brain .a 2334 to 2651 319 to 2       318/325
(97 %)
0 diff
(100 %id)
AA767668 germinal center B cell .a 2340 to 2731 391 to 1       391/391
(100 %)
4 diff
(99.0 %id)
AA978106 pooled .a 2341 to 2765 426 to 3   tiling clone,   424/426
(99 %)
0 diff
(100 %id)
AW078657 2 pooled high-grade transitional celltumors, genitourinary tract .a 2342 to 2764 423 to 1       423/423
(100 %)
0 diff
(100 %id)
AA758078   .a 2382 to 2764 400 to 19   AAA   382/382
(100 %)
1 diff
(99.8 %id)
AA193408 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2386 to 2764 400 to 14   AAA   387/392
(98 %)
10 diff
(97.5 %id)
AI638746 pooled germ cell tumors .a 2402 to 2764 362 to 1       362/362
(100 %)
3 diff
(99.2 %id)
AI284387 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2460 to 2765 307 to 2       306/307
(99 %)
0 diff
(100 %id)
Z25378 leg muscle, skeletal muscle .a 2463 to 2764 306 to 1       306/324
(94 %)
8 diff
(97.6 %id)
T96985 liver and spleen .a 2490 to 2757 270 to 1       270/428
(63 %)
5 diff
(98.9 %id)
AA652501   .a 2506 to 2765 294 to 37       258/294
(87 %)
0 diff
(100 %id)
AI499662 anaplastic oligodendroglioma, brain .a 2510 to 2764 255 to 1       255/255
(100 %)
1 diff
(99.7 %id)
AI343419 colon, colon tumor, RER+ .a 2529 to 2764 257 to 22   AAA   236/236
(100 %)
3 diff
(98.8 %id)
Z38750 brain, total brain .a 2530 to 2764 235 to 1       235/235
(100 %)
2 diff
(99.2 %id)
F02080 brain, total brain .a 2560 to 2764 205 to 1       205/205
(100 %)
2 diff
(99.1 %id)
AI749079 colon .a 2564 to 2767 217 to 14       204/232
(87 %)
0 diff
(100 %id)
AA774929 schizophrenic brain S-11 frontal lobe .a 2648 to 2763 116 to 1       116/116
(100 %)
2 diff
(98.3 %id)
AA777478 liver and spleen .a 2706 to 3160 455 to 1   tiling clone,   455/455
(100 %)
2 diff
(99.6 %id)
CR607189 HeLa cells Cot 25-normalized .b 1 to 1952 1 to 1952 exact tiling clone,   1952/1952
(100 %)
0 diff
(100 %id)
BU145608 dorsal root ganglia .b 1815 to 2611 1 to 809   tiling clone,   809/895
(90 %)
19 diff
(97.9 %id)
CN265308 embryonic stem cells, cell lines H1, H7, andH9 .b 1847 to 2551 1 to 706   tiling clone,   706/706
(100 %)
6 diff
(99.2 %id)
DR762854 embryonic stem .b 2391 to 3092 1 to 702   tiling clone,   702/702
(100 %)
1 diff
(99.9 %id)
DB471850 hippocampus .b 2414 to 2908 1 to 495       495/495
(100 %)
4 diff
(99.2 %id)
CB105055 Ascites, stomach .b 2684 to 3194 1 to 511   tiling clone,   511/511
(100 %)
2 diff
(99.7 %id)
AA432224.
matches multiple genes
  .b 2719 to 3183 1 to 464     also hits gene GGH 464/464
(100 %)
1 diff
(99.8 %id)
BF822645 kidney_tumor .b 2958 to 3243 293 to 16   tiling clone, Submitted on the opposite strand 278/293
(94 %)
0 diff
(100 %id)
AY597811   .c 1 to 783 1 to 783 S31G V46I F126S tiling clone,   783/783
(100 %)
4 diff
(99.5 %id)
BP391094 pancreatic islet .c 748 to 1245 498 to 1   tiling clone,   498/501
(99 %)
0 diff
(100 %id)
AW964946   .c 750 to 1351 1 to 600       600/602
(99 %)
22 diff
(96.4 %id)
G43053   .c 840 to 991 1 to 152       152/153
(99 %)
2 diff
(98.7 %id)
BF844261 head_neck .c 857 to 1289 17 to 448       432/458
(94 %)
15 diff
(96.8 %id)
BQ355247 head_neck .c 861 to 1280 44 to 465       422/466
(90 %)
15 diff
(96.8 %id)
BU786093 insulinoma, Pancreas .c 924 to 1352 431 to 1   tiling clone,   431/431
(100 %)
2 diff
(99.6 %id)
EC577249 Prostate .c 960 to 1060 1 to 100       100/100
(100 %)
1 diff
(99.0 %id)
EC521484 Prostate .c 1009 to 1103 1 to 95       95/96
(98 %)
4 diff
(95.9 %id)
EC549744 Prostate .c 1010 to 1105 1 to 96       96/96
(100 %)
0 diff
(100 %id)
BG493231 lung, mucoepidermoid carcinoma .d 1 to 813 1 to 832   tiling clone,   832/876
(94 %)
60 diff
(93.2 %id)
AW663155 2 pooled high-grade transitional celltumors, genitourinary tract .d 18 to 241 14 to 238   tiling clone,   225/238
(94 %)
6 diff
(97.5 %id)
AI561002 anaplastic oligodendroglioma, brain .d 527 to 1116 590 to 1   tiling clone,   590/590
(100 %)
5 diff
(99.2 %id)
AW613612 2 pooled high-grade transitional celltumors, genitourinary tract .d 715 to 1099 385 to 1       385/387
(99 %)
1 diff
(99.8 %id)
BX384309   .d 1082 to 2019 953 to 20   tiling clone,   934/987
(94 %)
8 diff
(99.2 %id)
BQ953061 epidermoid carcinoma, cell line, lung .d 1151 to 1921 1 to 772   tiling clone,   772/869
(88 %)
3 diff
(99.7 %id)
DA731216   .d 1663 to 2403 2 to 744   tiling clone, capped   743/743
(100 %)
5 diff
(99.4 %id)
CX869516 embryonic stem .d 2117 to 2880 1 to 764   tiling clone,   764/764
(100 %)
0 diff
(100 %id)
CB155061 brain .d 2147 to 2650 1 to 504       504/504
(100 %)
3 diff
(99.5 %id)
AV705086 adrenal gland .d 2187 to 2631 1 to 445   AAA   445/445
(100 %)
0 diff
(100 %id)
R88076 brain .d 2661 to 2992 8 to 340       333/342
(97 %)
7 diff
(98.0 %id)
BI116822 lung, small cell carcinoma .d 2750 to 3413 1 to 665   tiling clone,   665/806
(82 %)
16 diff
(98.1 %id)
DN992777 brain, whole brain .d 2999 to 3462 9 to 472   tiling clone,   464/472
(98 %)
6 diff
(98.8 %id)
BF526385 brain, glioblastoma with EGFR amplification .d 3050 to 3344 5 to 298       294/298
(98 %)
9 diff
(97.0 %id)
BC039154 Brain, glioblastoma with EGFR amplification .d 3057 to 4029 1 to 973 S31G V46I tiling clone, available from MGC, AAA   973/973
(100 %)
3 diff
(99.7 %id)
NM_182563.2   .d 3057 to 4029 1 to 973 S31G V46I RefSeq, AAA   973/973
(100 %)
3 diff
(99.7 %id)
TI_149286300   .d 3217 to 4029 887 to 79 E2P P3T A4R S5C C7V ... AAA   807/813
(99 %)
17 diff
(98.0 %id)
CV025006 mixed .d 3234 to 3897 1 to 664       664/664
(100 %)
3 diff
(99.6 %id)
TI_1948072597   .d 3234 to 3462 140 to 368       229/257
(89 %)
8 diff
(96.9 %id)
TI_1948072868   .d 3234 to 3443 135 to 344       210/238
(88 %)
8 diff
(96.7 %id)
TI_1948073159   .d 3234 to 3453 136 to 355       220/248
(88 %)
8 diff
(96.8 %id)
TI_1948073418   .d 3234 to 3434 134 to 334       201/229
(87 %)
8 diff
(96.6 %id)
TI_1948072869   .d 3253 to 3919 796 to 125       670/1443
(46 %)
11 diff
(99.3 %id)
TI_1948073420   .d 3284 to 3919 773 to 136       638/1115
(57 %)
19 diff
(98.3 %id)
BM548657 brain, hippocampus .d 3330 to 4031 2 to 703       702/1072
(65 %)
12 diff
(98.9 %id)
BM971914 lung .d 3446 to 4029 602 to 19   AAA   584/584
(100 %)
1 diff
(99.9 %id)
CX869441 embryonic stem .d 3492 to 4029 565 to 28   AAA   538/538
(100 %)
8 diff
(98.6 %id)
TI_1948073160   .d 3520 to 3919 528 to 129       400/427
(93 %)
0 diff
(100 %id)
AI992180 thymus, pooled .d 3522 to 4029 512 to 5       508/512
(99 %)
0 diff
(100 %id)
AA428543   .d 3552 to 4029 481 to 4       478/481
(99 %)
5 diff
(99.0 %id)
AV702883 adrenal gland .d 3565 to 4022 1 to 458       458/458
(100 %)
0 diff
(100 %id)
AU149327   .d 3570 to 4029 464 to 1       464/582
(79 %)
12 diff
(98.0 %id)
TI_1948072598   .d 3592 to 3919 456 to 129       328/355
(92 %)
0 diff
(100 %id)
AI372029 pooled germ cell tumors .d 3594 to 4022 458 to 30   AAA   429/435
(98 %)
2 diff
(99.6 %id)
AI827205 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 3615 to 4029 419 to 4       416/419
(99 %)
1 diff
(99.8 %id)
TI_1948073419   .d 3653 to 3919 392 to 126       267/294
(90 %)
0 diff
(100 %id)
R88077 brain .d 3757 to 4027 272 to 2       271/273
(99 %)
0 diff
(100 %id)
AA939223 pooled .d 3758 to 4029 274 to 4       271/274
(98 %)
0 diff
(100 %id)
AA627323 breast .d 3781 to 4026 244 to 1       244/244
(100 %)
2 diff
(99.2 %id)
CA337698 1st pharyngeal arch (pooled) .d 3798 to 4029 1 to 232   AAA   232/232
(100 %)
1 diff
(99.6 %id)
EC469808 Prostate .d 3883 to 3994 1 to 113       113/113
(100 %)
6 diff
(94.7 %id)
BF848006 lung_normal .e 1 to 246 275 to 30 P22L T75A tiling clone, Submitted on the opposite strand 246/278
(88 %)
4 diff
(98.6 %id)
DN996632 breast cancer, Mammary gland (cancer tissue) Gene PGPandC16orf79, variant not shown         Suspected internal deletion, this clone was ignored    
DB299618 cerebellum Gene PGPandC16orf79, variant not shown         Suspected internal deletion, this clone was ignored    
DA107754 cerebellum Gene PGPandC16orf79, variant not shown       capped Suspected internal deletion, this clone was ignored    
DB308682 hippocampus Gene PGPandC16orf79, variant not shown         This clone was ignored    
DA314586 hippocampus Gene PGPandC16orf79, variant not shown       capped This clone was ignored    
AI742421 pooled Gene PGPandC16orf79, variant not shown         Suspected internal deletion, this clone was ignored    
AW139709   Gene PGPandC16orf79, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BI668448 brain, hypothalamus Gene PGPandC16orf79, variant not shown         Suspected internal deletion, this clone was ignored    
BM020486 astrocytoma grade IV, cell line, brain Gene PGPandC16orf79, variant not shown       AAA Suspected internal deletion, this clone was ignored    
TI_44344632   Gene PGPandC16orf79, variant not shown         Suspected internal deletion, this clone was ignored    
TI_59391273   Gene PGPandC16orf79, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DC